---
title: "Prof Nicholas Barrie La Thangue — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f2fed2da-532e-4cee-b109-80926ba9083b
json: https://whiteintel.dev/api/public/dossier/f2fed2da-532e-4cee-b109-80926ba9083b
identifier: psc:2OfeG-inrcmb9wCr2h6wxGFUNFo
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Prof Nicholas Barrie La Thangue

**Type:** Person  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:2OfeG-inrcmb9wCr2h6wxGFUNFo`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f2fed2da-532e-4cee-b109-80926ba9083b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f2fed2da-532e-4cee-b109-80926ba9083b  

## Ownership & control

### Holdings / subsidiaries

- **CELLERON THERAPEUTICS LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/c486cb95-4643-5ccc-877b-950c57ff1877

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Prof Nicholas Barrie La Thangue**. Human view: https://whiteintel.dev/entity/f2fed2da-532e-4cee-b109-80926ba9083b · Structured JSON: https://whiteintel.dev/api/public/dossier/f2fed2da-532e-4cee-b109-80926ba9083b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._